CVT-2738

• Description :

  CVT-2738 is an orally active metabolite of Ranolazine (HY-B0280) . CVT-2738 has a protective effect against Isoprenaline (HY-108353) -induced myocardial ischemia in mice. CVT-2738 can be used in myocardial ischemia research[1].

• Product Name Alternative :

  RS-94287

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Drug Metabolite

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/cvt-2738.html

• Purity :

  99.81

• Solubility :

  DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles :

  O=C(NC1=C(C)C=CC=C1C)CN2CCNCC2

• Molecular Formula :

  C14H21N3O

• Molecular Weight :

  247.34

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Yao Z, et al. Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities. Chem Pharm Bull (Tokyo) . 2009 Nov;57 (11) :1218-22.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [5294-61-1]